AscellaHealth
Robert J. Gilkin Jr., RPh, MBA has extensive experience in the pharmaceutical industry, specializing in market access, trade strategy, and commercial operations. Robert has held key leadership positions in various companies, leading teams and driving significant revenue growth through strategic planning and execution. Robert has a strong track record of launching new products, developing market access programs, managing payer relationships, and implementing pricing strategies. With their comprehensive expertise in healthcare marketing and biotechnology, Robert has successfully navigated complex markets and maximized market share for various pharmaceutical products.
AscellaHealth
AscellaHealth is a global Specialty Pharmacy and Healthcare services organization serving payers, providers, life sciences and patients, offering a comprehensive portfolio of customized, tech-enabled specialty pharmaceutical and medical management services. AscellaHealth’s unique, patient-centric approach is built upon proprietary technology processes for innovative programs and services optimizing health outcomes and quality of life for patients with complex, chronic conditions or rare diseases that require specialty medications and/or gene and cell therapies. Our end-to-end specialty pharmacy services support all specialty disease states and include, Pre-Commercialization and Market Access Solutions, Hub and Patient Support, Limited Distribution Drug Strategies, Proprietary Specialty Pharmacy and Infusion Network, Customized Clinical Programs, Technology-based Patient Engagement, Medical and Pharmacy Benefit Management, Drug Rebate Programs, and Real-Time Prescription Data and Analytics via our proprietary technology platform. AscellaHealth is at the forefront of the Specialty Pharmacy industry and has proactively developed a customizable suite of services and programs based on shifting trends and market conditions within the specialty pharmacy industry. We are your premier partner in Specialty Pharmacy and Healthcare solutions for improving access, optimizing outcomes, and enhancing the patient journey.